Barclays’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$274K Buy
12,179
+12,116
+19,232% +$273K ﹤0.01% 3354
2025
Q1
$1K Hold
63
﹤0.01% 4342
2024
Q4
$1K Hold
63
﹤0.01% 4342
2024
Q3
$1K Hold
63
﹤0.01% 4298
2024
Q2
$1K Hold
63
﹤0.01% 4161
2024
Q1
$1K Hold
63
﹤0.01% 4144
2023
Q4
$1K Hold
63
﹤0.01% 4177
2023
Q3
$1K Sell
63
-10
-14% -$159 ﹤0.01% 4221
2023
Q2
$1K Sell
73
-404
-85% -$5.53K ﹤0.01% 4210
2023
Q1
$37K Buy
477
+11
+2% +$853 ﹤0.01% 3858
2022
Q4
$39K Hold
466
﹤0.01% 3858
2022
Q3
$43K Hold
466
﹤0.01% 3704
2022
Q2
$70K Sell
466
-508
-52% -$76.3K ﹤0.01% 3611
2022
Q1
$237K Hold
974
﹤0.01% 3213
2021
Q4
$294K Buy
974
+470
+93% +$142K ﹤0.01% 2722
2021
Q3
$209K Buy
504
+423
+522% +$175K ﹤0.01% 2962
2021
Q2
$24K Sell
81
-474
-85% -$140K ﹤0.01% 3672
2021
Q1
$114K Buy
555
+47
+9% +$9.65K ﹤0.01% 3329
2020
Q4
$102K Sell
508
-73
-13% -$14.7K ﹤0.01% 2970
2020
Q3
$97K Sell
581
-56
-9% -$9.35K ﹤0.01% 3048
2020
Q2
$158K Buy
637
+149
+31% +$37K ﹤0.01% 2927
2020
Q1
$89K Sell
488
-112
-19% -$20.4K ﹤0.01% 2876
2019
Q4
$173K Sell
600
-21
-3% -$6.06K ﹤0.01% 3246
2019
Q3
$170K Sell
621
-41
-6% -$11.2K ﹤0.01% 3136
2019
Q2
$249K Buy
662
+474
+252% +$178K ﹤0.01% 3087
2019
Q1
$50K Buy
188
+119
+172% +$31.6K ﹤0.01% 3651
2018
Q4
$15K Sell
69
-174
-72% -$37.8K ﹤0.01% 3464
2018
Q3
$109K Buy
243
+195
+406% +$87.5K ﹤0.01% 3368
2018
Q2
$20K Sell
48
-325
-87% -$135K ﹤0.01% 3654
2018
Q1
$204K Buy
373
+282
+310% +$154K ﹤0.01% 2829
2017
Q4
$55K Sell
91
-352
-79% -$213K ﹤0.01% 3309
2017
Q3
$205K Buy
+443
New +$205K ﹤0.01% 2382
2017
Q2
Hold
0
4112